Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A current review of COVID-19 for the cardiovascular specialist.
Lang JP, Wang X, Moura FA, Siddiqi HK, Morrow DA, Bohula EA. Lang JP, et al. Among authors: moura fa. Am Heart J. 2020 Aug;226:29-44. doi: 10.1016/j.ahj.2020.04.025. Epub 2020 May 3. Am Heart J. 2020. PMID: 32497913 Free PMC article. Review.
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study.
Carmo HRP, Castillo AR, Bonilha I, Gomes EIL, Barreto J, Moura FA, Davanzo GG, de Brito Monteiro L, Muraro SP, Fabiano de Souza G, Morari J, Galdino FE, Brunetti NS, Reis-de-Oliveira G, Carregari VC, Nadruz W, Martins-de-Souza D, Farias AS, Velloso LA, Proenca-Modena JL, Mori MA, Loh W, Bhatt DL, Yellon DM, Davidson SM, De Oliveira PG, Moraes-Vieira PM, Sposito AC. Carmo HRP, et al. Among authors: moura fa. Front Pharmacol. 2024 Oct 7;15:1402032. doi: 10.3389/fphar.2024.1402032. eCollection 2024. Front Pharmacol. 2024. PMID: 39434905 Free PMC article.
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Sposito AC, Breder I, Barreto J, Breder J, Bonilha I, Lima M, Oliveira A, Wolf V, Luchiari B, do Carmo HR, Munhoz D, Oliveira D, Coelho-Filho OR, Coelho OR, Matos-Souza JR, Moura FA, de Carvalho LSF, Nadruz W, Quinaglia T, Kimura-Medorima ST; EXCEED-BHS3 Group. Sposito AC, et al. Among authors: moura fa. Cardiovasc Diabetol. 2022 Aug 6;21(1):147. doi: 10.1186/s12933-022-01584-8. Cardiovasc Diabetol. 2022. PMID: 35933413 Free PMC article. Clinical Trial.
Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials.
de Mesquita YLL, Pera Calvi I, Reis Marques I, Almeida Cruz S, Padrao EMH, Carvalho PEP, da Silva CHA, Cardoso R, Moura FA, Rafalskiy VV. de Mesquita YLL, et al. Among authors: moura fa. Int J Obes (Lond). 2023 Oct;47(10):883-892. doi: 10.1038/s41366-023-01337-x. Epub 2023 Jul 17. Int J Obes (Lond). 2023. PMID: 37460681 Review.
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Nogueira ACC, Barreto J, Moura FA, Luchiari B, Abuhab A, Bonilha I, Nadruz W, Gaziano JM, Gaziano T, de Carvalho LSF, Sposito AC; Brazilian Heart Study Group. Nogueira ACC, et al. Among authors: moura fa. Health Econ Rev. 2023 Oct 25;13(1):50. doi: 10.1186/s13561-023-00466-3. Health Econ Rev. 2023. PMID: 37878108 Free PMC article.
165 results